https://mospsyde-ntu.github.io/tags/particle-engineering/Particle EngineeringHugo Blox Builder (https://hugoblox.com)en-usWed, 01 Apr 2026 00:00:00 +0000https://mospsyde-ntu.github.io/media/icon_hu_982c5d63a71b2961.pnghttps://mospsyde-ntu.github.io/tags/particle-engineering/https://mospsyde-ntu.github.io/projects/chem-pharm-design/Wed, 01 Apr 2026 00:00:00 +0000https://mospsyde-ntu.github.io/projects/chem-pharm-design/<h2 id="project-vision">Project Vision</h2> <p>To be updated.</p> <h2 id="project-duration">Project Duration</h2> <p>2026-2031</p> <h2 id="team">Team</h2> <ul> <li>PI: Kensaku Matsunami</li> </ul> <!-- ## Medical Need Neurological disorders affect millions globally: - **Spinal Cord Injury**: 300,000+ Americans living with paralysis - **ALS (Lou Gehrig's Disease)**: 30,000+ patients losing motor function - **Stroke**: 800,000+ survivors with lasting disabilities annually - **Locked-in Syndrome**: Patients conscious but unable to move or speak Current assistive technologies are limited by: - Low bandwidth communication (2-3 bits/second) - Poor signal stability over time - Invasive surgical procedures - Limited functionality and user experience ## Technical Innovation ### Advanced Neural Decoding - **High-Dimensional Signal Processing**: Analyzing 1000+ simultaneous neural channels - **Temporal Dynamics**: Capturing neural patterns across millisecond timescales - **Adaptive Learning**: Models that improve with user practice - **Robust Decoding**: Performance maintained despite signal degradation ### Machine Learning Architecture - **Recurrent Neural Networks**: Modeling temporal dependencies in neural data - **Transformer Models**: Attention mechanisms for neural sequence processing - **Federated Learning**: Privacy-preserving training across patient data - **Transfer Learning**: Adapting models between different patients ### Multi-Modal Integration - **Neural Signals**: Invasive and non-invasive electrode recordings - **Muscle Activity**: EMG signals from residual muscle function - **Eye Tracking**: Gaze-based interfaces for communication - **Brain Stimulation**: Closed-loop stimulation for rehabilitation ## Breakthrough Results ### Motor Control Restoration - **Typing Speed**: 90 characters/minute using thought alone (vs. 40 previous best) - **Prosthetic Control**: Fine motor control of robotic arms with 96% accuracy - **Real-time Performance**: <100ms latency for responsive control ### Communication Enhancement - **Speech Synthesis**: Converting intended speech to audio at 62 words/minute - **Text Generation**: Direct thought-to-text at 18 words/minute - **Emotional Expression**: Detecting and conveying emotional states ### Clinical Validation - **Patient Studies**: 25 participants across 4 clinical sites - **Long-term Stability**: Signals maintained for 18+ months post-implant - **Safety Profile**: Zero serious adverse events in 500+ patient-months ## Clinical Trials ### Phase I Safety Study (Completed) - **Participants**: 12 patients with chronic spinal cord injury - **Primary Endpoint**: Safety of chronic implantation (achieved) - **Secondary Endpoints**: Signal quality and preliminary efficacy - **Publication**: *New England Journal of Medicine* (2024) ### Phase II Efficacy Trial (Ongoing) - **Participants**: 50 patients across multiple conditions - **Primary Endpoint**: Functional improvement in daily activities - **Innovation**: First adaptive BCI system in clinical trials - **Timeline**: Results expected Q4 2024 ### Pediatric Study (Planning) - **Population**: Children with cerebral palsy and genetic disorders - **Focus**: Developmental plasticity and long-term outcomes - **Ethics**: Extensive pediatric ethics review process ## Technology Platform ### Hardware Development - **Ultra-High Density Arrays**: 10,000+ electrode microarrays - **Wireless Transmission**: Tetherless data transmission at 1Gbps - **Biocompatible Materials**: Long-term implant stability - **Miniaturization**: Reducing system size for aesthetic appeal ### Software Infrastructure - **Real-time Processing**: Sub-millisecond neural decoding - **Cloud Integration**: Secure patient data management - **Mobile Applications**: User-friendly control interfaces - **Calibration Protocols**: Daily system optimization ### AI Model Development - **Neural Architecture Search**: Automated model design for each patient - **Continual Learning**: Models that adapt to neural signal changes - **Interpretability**: Understanding what neural patterns represent - **Robustness**: Performance under real-world conditions ## Industry Partnerships ### Medical Device Companies - **Medtronic**: Neurostimulation and implant expertise - **Boston Scientific**: Electrode array manufacturing - **Abbott/St. Jude**: Wireless data transmission systems ### Technology Giants - **Meta Reality Labs**: AR/VR integration for BCI control - **Google Health**: AI model development and validation - **Microsoft Research**: Cloud computing and accessibility tools ### Pharmaceutical Companies - **Biogen**: Neurological disorder patient populations - **Roche/Genentech**: Biomarker discovery and validation - **Novartis**: Gene therapy combination approaches ## Regulatory Strategy ### FDA Breakthrough Device Designation - **Status**: Received breakthrough designation in 2023 - **Advantage**: Expedited review pathway and frequent FDA communication - **Milestones**: IDE approval for pivotal trial planned 2025 ### International Approvals - **CE Mark (Europe)**: Regulatory submission planned 2025 - **Health Canada**: Pre-submission meetings initiated - **Japan PMDA**: Regulatory strategy development ## Ethical Considerations ### Neuroethics Framework - **Privacy Protection**: Secure handling of neural data - **Informed Consent**: Comprehensive understanding of risks/benefits - **Enhancement vs. Treatment**: Clear boundaries for medical applications - **Identity and Agency**: Preserving patient autonomy and sense of self ### Advisory Boards - **Patient Advisory Board**: BCI users guiding development priorities - **Ethics Review Board**: Ongoing ethical oversight - **Disability Rights Organizations**: Ensuring community needs are met ## Educational Impact ### Training Programs - **BCI Engineering Certificate**: 1-year professional program - **Medical Device Innovation Course**: For clinicians and engineers - **Neuroethics Workshops**: Addressing societal implications ### Public Engagement - **Museum Exhibits**: Interactive BCI demonstrations - **Science Festivals**: Public education about neurotechnology - **Patient Stories**: First-person accounts of BCI benefits ## Economic Potential ### Market Opportunity - **BCI Market Size**: $3.7B by 2027 (27% CAGR) - **Addressable Population**: 5.4M people in US could benefit - **Healthcare Savings**: $50B annually in improved independence ### Commercialization Path - **Licensing Strategy**: Technology transfer to medical device companies - **Startup Formation**: University spin-off company development - **IP Portfolio**: 15 patent applications filed, 3 granted ## Global Research Network ### International Collaborations - **University of Cambridge**: Computational neuroscience expertise - **Swiss Federal Institute of Technology**: Neural interface engineering - **University of Tokyo**: Robotics and prosthetics integration - **Tel Aviv University**: Machine learning for neural data ### Data Sharing Consortium - **Brain Data Standards**: Developing common data formats - **Multi-site Studies**: Coordinated trials across institutions - **Reproducible Research**: Open protocols and analysis code ## Social Impact Stories ### Patient Testimonials - **"I can hug my daughter again"** - John, spinal cord injury patient - **"Speaking my thoughts for the first time in 10 years"** - Maria, ALS patient - **"Independence I thought I'd never have"** - David, stroke survivor ### Caregiver Relief - **Reduced Care Burden**: 40% decrease in daily assistance needed - **Family Quality of Life**: Improved relationships and communication - **Economic Benefits**: Reduced long-term care costs ## Research Publications ### High-Impact Publications 1. Kim, S., Smith, J., et al. "Adaptive Neural Interfaces for Motor Restoration." *Nature Neuroscience* **31**, 123-135 (2024) - **Editor's Choice** 2. Chen, M., Kim, S., et al. "Real-time Speech Synthesis from Neural Signals." *Cell* **187**, 456-470 (2024) - **Cover Article** 3. Davis, E., et al. "Federated Learning for Brain-Computer Interfaces." *Nature Machine Intelligence* **6**, 78-89 (2024) ### Conference Leadership - **Society for Neuroscience 2024**: Symposium organizer - "AI in Neural Interfaces" - **IEEE Neural Engineering Conference**: Program committee member - **Computational and Systems Neuroscience (Cosyne)**: Workshop chair ## Future Milestones ### Near-term Goals (2024-2025) - Complete Phase II clinical trial enrollment - Submit FDA approval application (PMA) - Launch commercial partnership negotiations - Train 50+ clinicians in BCI implantation ### Long-term Vision (2026-2029) - FDA approval and market launch - International regulatory approvals - Establish BCI centers of excellence - Democratize access through insurance coverage ## Recruitment & Collaboration ### Open Positions - **Postdoctoral Researcher**: Neural signal processing and ML - **Clinical Research Coordinator**: Managing multi-site trials - **Biomedical Engineer**: Hardware/software integration - **Regulatory Affairs Specialist**: FDA submission and compliance ### Partnership Opportunities - **Clinical Sites**: Hospitals with neurosurgery capabilities - **Patient Organizations**: ALS Association, Christopher Reeve Foundation - **Technology Companies**: Hardware and software development partners - **Investors**: Series A funding for commercialization ### Contact Information - **Principal Investigator**: Prof. Jane Smith (jane.smith@example.edu) - **Clinical Director**: Dr. Sarah Kim (sarah.kim@example.edu) - **Engineering Lead**: Dr. Michael Chen (michael.chen@example.edu) - **Business Development**: partnerships@example.edu -->